BlueLight Therapeutics is Biotechnology in United States that focus on inexpensively measure business. Founded in 2008. They cover business area such as developer, novel therapeutic molecule, structural change, biomolecule, real-time, structural activity-base therapeutic, drug, both protein structure, its function, pharmaceutical and biotechnology company, significant insight, many human disease.
2008
( 16 years old in 2024 )
Inexpensively Measure
-
170 Harbor Way
Suite 100 South
San Francisco, CA 94080
United States
Private
developernovel therapeutic moleculestructural changebiomoleculereal-timestructural activity-base therapeuticdrugboth protein structureits functionpharmaceutical and biotechnology companysignificant insightmany human disease
* We use standard office opening hours in near BlueLight Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BlueLight Therapeutics is Biotechnology business from United States that founded in 2008 (16 years old in 2024), BlueLight Therapeutics business is focusing on Inexpensively Measure.
BlueLight Therapeutics headquarter office and corporate office address is located in 170 Harbor Way Suite 100 South San Francisco, CA 94080 United States.
BlueLight Therapeutics was founded in United States.
In 2024, BlueLight Therapeutics is currently focus on inexpensively measure sector.
Above is snippet of Google Trends for "inexpensively measure" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BlueLight Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.